MRI-guided laser ablation of neuroendocrine tumor hepatic metastases.
Acta Radiol Short Rep
; 3(1): 2047981613499753, 2014 Jan.
Article
em En
| MEDLINE
| ID: mdl-24778794
ABSTRACT
BACKGROUND:
Neuroendocrine tumors (NET) represent a therapeutically challenging and heterogeneous group of malignancies occurring throughout the body, but mainly in the gastrointestinal system.PURPOSE:
To describe magnetic resonance imaging (MRI)-guided laser ablation of NET liver metastases and assess its role within the current treatment options and methods. MATERIAL ANDMETHODS:
Two patients with NET tumor hepatic metastases were treated with MRI-guided interstitial laser ablation (LITT). Three tumors were treated. Clinical follow-up time was 10 years.RESULTS:
Both patients were successfully treated. There were no local recurrences at the ablation site during the follow-up. Both patients had survived at 10-year follow-up. One patient is disease-free.CONCLUSION:
MRI-guided laser ablation can be used to treat NET tumor liver metastases but combination therapy and a rigorous follow-up schedule are recommended.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Revista:
Acta Radiol Short Rep
Ano de publicação:
2014
Tipo de documento:
Article